Kawasaki Disease – Options for Anti-Platelet Therapy

Austin Journal of Pharmacology and Therapeutics
doi 10.26420/austinjpharmacolther.2017.1089
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Austin Publishing Group

Related search

Treatment Options for Refractory Kawasaki Disease

Yangtze Medicine
2020English

Platelet Activation Dynamics Evaluated Using Platelet-Derived Microparticles in Kawasaki Disease

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Gamma Globulin Therapy in Kawasaki Disease

Pediatric Research
Child HealthPediatricsPerinatology
2003English

Targeting Phosphodiesterases in Anti-Platelet Therapy

Handbook of Experimental Pharmacology
BiochemistryToxicologyPharmaceuticsPharmacology
2012English

Search for an Optimal Efficacy-To-Safety Ratio for Anti-Platelet Therapy of Ischemic Heart Disease

Medical Council
2018English

Circulating Platelet-Neutrophil Aggregates Play a Significant Role in Kawasaki Disease

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Platelet Tocopherol Levels in Mucocutaneous Lymph Node Syndrome (MCLS: Kawasaki Disease).

Journal of Nutritional Science and Vitaminology
MedicineNutritionDietetics
1983English

Parameters to Guide Rescue Therapy for Intravenous Immunoglobulin-Resistant Kawasaki Disease

Journal of Advances in Medicine and Medical Research
2017English

Anti-Platelet Therapy: Cyclo-Oxygenase Inhibition and the Use of Aspirin With Particular Regard to Dual Anti-Platelet Therapy

British Journal of Clinical Pharmacology
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy